Summary
The CLOSURE I trial [NCT00201461] was conducted to determine if percutaneous patent foramen ovale closure using the STARFlex® Septal Closure System in combination with medical therapy, is superior to medical therapy alone to prevent recurrent ischemic neurological symptoms in patients with transient ischemic attack or ischemic stroke.
- Neurology
- Interventional Techniques & Devices
- Episodic & Paroxysmal Disorders Clinical Trials
- © 2011 MD Conference Express
Tools
No Advantage for Percutaneous Closure of PFO versus Medical Therapy in Reducing Recurrent Neurological Events
Permalink:
Table of contents
Cited By...
- No citing articles found.